Salarius Pharmaceuticals (SLRX) 10-Q2018 Q1 Quarterly report

Filed: 2 May 18, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accessibility, advocacy, attacked, aware, breach, breached, Bulletin, case, ceased, characterized, clarity, compel, complexity, comply, conceal, Concurrent, confidential, confidentiality, configuration, consideration, contract, corrective, criminal, database, demand, deployment, detect, discovered, distinct, distracting, dose, electrical, element, eligible, enactment, enforceable, enforcement, engineering, environment, espionage, expedient, expertise, exploited, federal, firm, foreign, inadvertent, inappropriate, incomplete, infrastructure, inhibit, inhibition, involuntary, ion, judgment, lapsed, large, larger, litigation, lose, lost, malware, mandatory, meet, misappropriation, mobile, molecule, mouth, nation, notification, oversight, pay, payroll, persistence, pertaining, population, prevalent, privacy, prolonged, provisional, published, range, ransomware, receptor, recover, recruiting, reflex, reliability, reproduce, reputation, reputational, resistance, SAB, satisfaction, Scope, separately, small, social, sophisticated, sophistication, stomach, store, stored, stretch, subcontract, sum, system, telecommunication, terrorism, thought, threaten, throat, timeframe, transfer, transferred, transferring, transient, transmit, TRP, trust, turn, type, ultimately, unauthorized, unintentional, verify, vulnerable, war, wide

Removed: accelerate, account, accurately, acting, administered, agent, apply, arrange, arrangement, assured, Australia, baseline, campaign, capitalizing, clarifying, collectibility, commercially, comprised, controlled, cramp, deferral, determinable, disposal, Dr, endpoint, equivalent, establish, evaluate, geographic, immaterial, implement, implementation, Inotek, interpretive, issue, joining, launch, leadership, life, LIFO, location, MA, McVicar, minimum, occur, occurred, October, original, partner, permit, persuasive, predictable, President, principal, produced, promise, proper, quantify, relation, requiring, retained, revaluation, ROU, run, secondary, served, shelf, shipment, short, strong, sublease, submission, unchanged, Vice, William, wrote

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Associated SLRX transcripts

SLRX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report on Form 10-Q of Flex Pharma, Inc. (the "Company") for the fiscal period ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



		/s/ William McVicar
		William McVicar, Ph.D.
May 2, 2018		President and Chief Executive Officer (Principal Executive Officer)



		/s/ John McCabe
		John McCabe
May 2, 2018		Chief Financial Officer (Principal Financial and Accounting Officer)

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Flex Pharma, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.